These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4214608)

  • 41. A comparative study of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) and imidazole carboxamide (NSC 45388) with vincristine (NSC 67574) in the palliation of disseminated malignant melanoma.
    Ahmann DL; Hahn RG; Bisel HF
    Cancer Res; 1972 Nov; 32(11):2432-4. PubMed ID: 5082592
    [No Abstract]   [Full Text] [Related]  

  • 42. Proceedings: Chemotherapy of soft-tissue sarcomas.
    Talley RW
    Proc Natl Cancer Conf; 1972; 7():89-900. PubMed ID: 4358072
    [No Abstract]   [Full Text] [Related]  

  • 43. Remission of uterine leiomyosarcomas treated with vincristine, Adriamycin, and dimethyl-triazeno-imidazole carboximide.
    Azizi F; Bitran J; Javehari G; Herbst AL
    Am J Obstet Gynecol; 1979 Feb; 133(4):379-81. PubMed ID: 433999
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of combination adriamycin (NSC-123127) and DTIC (NSC-45388) in children with advanced stage IV neuroblastoma.
    Leikin S; Bernstein I; Evans A; Finklestein J; Hittle R; Klemperer M
    Cancer Chemother Rep; 1975; 59(5):1015-8. PubMed ID: 1106842
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cyclophosphamide, vincristine, adriamycin, and dimethyl-triazeno imidazole carboxamide (CYVADIC) for sarcomas of the female genital tract.
    Piver MS; DeEulis TG; Lele SB; Barlow JJ
    Gynecol Oncol; 1982 Dec; 14(3):319-23. PubMed ID: 6897542
    [No Abstract]   [Full Text] [Related]  

  • 46. Results of a randomized study comparing DTIC with TIC mustard in malignant melanoma.
    Costanza ME; Nathanson L; Costello WG; Wolter J; Brunk SF; Colsky J; Hall T; Oberfield RA; Regelson W
    Cancer; 1976 Apr; 37(4):1654-9. PubMed ID: 769936
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Chemotherapy of malignant melanoma].
    Wagenknecht L
    Schweiz Med Wochenschr; 1973 Oct; 103(41):1426-8. PubMed ID: 4127413
    [No Abstract]   [Full Text] [Related]  

  • 48. Metabolism of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in human and animal tumor tissue.
    Mizuno NS; Humphrey EW
    Cancer Chemother Rep; 1972 Aug; 56(4):465-72. PubMed ID: 5081589
    [No Abstract]   [Full Text] [Related]  

  • 49. Clinical comparison of adriamycin and a combination of methyl-CCNU and imidazole carboxamide in disseminated malignant melanoma.
    Ahmann DL; Bisel HF; Edmonson JH; Hahn RG; Eagan RT; O'Connell MJ; Frytak S
    Clin Pharmacol Ther; 1976 Jun; 19(6):821-4. PubMed ID: 773589
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preliminary clinical trial and the physiologic disposition of 4(5)-(3,3-dimethyl-1-triazeno)imidazole-5(4)-carboxamide in man.
    Skibba JL; Ramirez G; Beal DD; Bryan GT
    Cancer Res; 1969 Nov; 29(11):1944-51. PubMed ID: 5358212
    [No Abstract]   [Full Text] [Related]  

  • 51. Combination chemotherapy with adriamycin (NSC-123127) and 1-(2-chloroethyl)-3-cyclohexyl 1-nitrosourea (CCNU; NSC-79037).
    Einhorn LH; Livingston RB; Gottlieb JA
    Cancer Chemother Rep; 1973; 57(4):437-45. PubMed ID: 4586951
    [No Abstract]   [Full Text] [Related]  

  • 52. [Dimethyl-triazeno-imidazole-carboxamide (DTIC) in combination chemotherapy for childhood neuroblastoma (author's transl)].
    Mutz ID; Urban CE
    Wien Klin Wochenschr; 1978 Dec; 90(24):867-70. PubMed ID: 741754
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The crystal structure of the antitumor agent 5-(3,3-dimethyl-l-triazeno)imidazole-4-carboxamide monohydrate hydrochloride (NSC-45388).
    Edwards SL; Sherfinski JS; Marsh RE
    J Am Chem Soc; 1974 Apr; 96(8):2593-7. PubMed ID: 4833711
    [No Abstract]   [Full Text] [Related]  

  • 54. Comparative studies on the chemical stability and therapeutic effectiveness of water-insoluble 5-(3,3-bis(2-chloroethyl)-1-triazeno)imidazole-4-carboxamide (NSC-82196) and its water-soluble hydrochloride against L1210 mouse leukemia.
    Woodman RJ; Kline I; Field RB; Gang M
    Cancer Chemother Rep; 1973; 57(4):383-91. PubMed ID: 4762437
    [No Abstract]   [Full Text] [Related]  

  • 55. Antimetastatic action and hematological toxicity of p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide used as prophylactic adjuvants to surgical tumor removal in mice bearing B16 melanoma.
    Sava G; Giraldi T; Lassiani L; Nisi C
    Cancer Res; 1984 Jan; 44(1):64-8. PubMed ID: 6690062
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intermittent treatment of metastatic malignant melanoma with high-dose 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388).
    Cowan DH; Bergsagel DE
    Cancer Chemother Rep; 1971 Apr; 55(2):175-81. PubMed ID: 5118686
    [No Abstract]   [Full Text] [Related]  

  • 57. Adaptation of a colorimetric determination of 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide (NSC-45388) and 5-[3,3-bis(2-chloroethyl)-1-triazeno]imidazole-4-carboxamide (NSC-82196) to blood.
    Field RB; Hoffman G; Waravdekar VS; Kline I
    Cancer Chemother Rep; 1969 Jun; 53(3):199-202. PubMed ID: 4980814
    [No Abstract]   [Full Text] [Related]  

  • 58. [Dimethyl-triazeno-imidazol-carboxamide (DTIC)--a new cytostatic agent].
    Klepp O
    Tidsskr Nor Laegeforen; 1975 Sep; 95(27):1550-1. PubMed ID: 1179374
    [No Abstract]   [Full Text] [Related]  

  • 59. Role of DTIC (NSC-45388) in the chemotherapy of sarcomas.
    Gottlieb JA; Benjamin RS; Baker LH; O'Bryan RM; Sinkovics JG; Hoogstraten B; Quagliana JM; Rivkin SE; Bodey GP; Rodriguez V; Blumenschein GR; Saiki JH; Coltman C; Burgess MA; Sullivan P; Thigpen T; Bottomley R; Balcerzak S; Moon TE
    Cancer Treat Rep; 1976 Feb; 60(2):199-203. PubMed ID: 769974
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of solid tumors in children.
    Finklestein JZ; Albo V; Ertel I; Hammond D
    Cancer Chemother Rep; 1975; 59(2 Pt 1):351-7. PubMed ID: 167936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.